-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, WE0pCy4N0NgC/w1PxrWe0AfBFmMHIr5cR6l9vphqWcn8l0K3WjqosBADEIVmVFQ/ UrLA6Dm5FKFeH7rstnecwQ== 0001181153-07-000006.txt : 20070829 0001181153-07-000006.hdr.sgml : 20070829 20070829112148 ACCESSION NUMBER: 0001181153-07-000006 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070829 FILED AS OF DATE: 20070829 DATE AS OF CHANGE: 20070829 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PHARMACEUTICAL PRODUCT DEVELOPMENT INC CENTRAL INDEX KEY: 0001003124 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 561640186 STATE OF INCORPORATION: NC FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 929 NORTH FRONT STREET CITY: WILMINGTON STATE: NC ZIP: 28401 BUSINESS PHONE: 9102510081 MAIL ADDRESS: STREET 1: 929 NORTH FRONT STREET CITY: WILMINGTON STATE: NC ZIP: 28401 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: COVINGTON PAUL S CENTRAL INDEX KEY: 0001181153 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-27570 FILM NUMBER: 071085931 BUSINESS ADDRESS: STREET 1: PHARMACEUTICAL PRODUCT DEVELOPMENT INC STREET 2: 3151 S 17TH ST CITY: WILMINGTON STATE: DE ZIP: 28412 BUSINESS PHONE: 9102510081 MAIL ADDRESS: STREET 1: 3116 BRAEMAR DRIVE CITY: WILMINGTON STATE: NC ZIP: 28401 4 1 edgar.xml PRIMARY DOCUMENT X0202 4 2007-08-29 0001003124 PHARMACEUTICAL PRODUCT DEVELOPMENT INC PPDI 0001181153 COVINGTON PAUL S 3116 BRAEMAR DRIVE WILMINGTON NC 28409 0 1 0 0 Executive Vice President Common Stock 2007-08-29 4 S 0 9045 35.09 D 0 D Stock Options (to buy) 21.19 2006-11-16 2014-11-15 Common Stock 25000 50000 D Stock Options (to buy) 34.62 2007-02-22 2016-02-21 Common Stock 40000 40000 D Stock Options (to buy) 33.61 2008-02-21 2017-02-20 Common Stock 30000 30000 D Shares were acquired through the company's employee stock purchase plan. This option will vest in increments of 25,000 on 11/16/07 and 11/16/08. This option will vest as follows: 13,333 on 2/22/07; 13,333 on 2/22/08 and 13,334 on 2/22/09. This option will vest in increments of 10,000 on 2/21/08, 2/21/09 and 2/21/10. This report is being filed voluntarily to report the Reporting Person's purchase of shares under the Company's Employee Stock Purchase Plan. Lisa C. Noecker attorney-in-fact for Paul S. Covington 2007-08-29 -----END PRIVACY-ENHANCED MESSAGE-----